MedTrace Logo

The Role of Matrix Metalloproteinase 2 and 9 Enzymes in Developing Chronic Thromboembolic Pulmonary Hypertension

NCT04773028 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 48

Last updated 2021-08-10

Study results available
· View outcomes & findings →

Summary

Chronic thromboembolic pulmonary hypertension is an occlusive disease in pulmonary artery.Matrix metalloproteinase enzymes play a substantial role of extracellular matrix remodeling. The clot formed in chronic thromboembolic pulmonary hypertension does not melt and turns into a fibrous state, it occludes the pulmonary artery.In this study, investigators aimed to investigate the role of matrix metalloproteinase enzymes in pulmonary arterial wall remodeling in patients with chronic thromboembolic pulmonary hypertension

Conditions

  • Chronic Thromboembolic Pulmonary Hypertension

Interventions

OTHER

matrix metalloproteinase enzymes 2 and 9

concentration of matrix metalloproteinase 2 and 9 enzymes

Sponsors & Collaborators

  • AHMET ZENGIN

    lead OTHER_GOV

Principal Investigators

  • mehmet yanartas · kartal kosuyolu hıgh specıalty training and research hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-07-01
Primary Completion
2021-05-04
Completion
2021-05-04

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04773028 on ClinicalTrials.gov